Rituximab used as a single agent for autoimmune hemolytic anemia (AIHA) in treatment naive chronic lymphocytic leukemia (CLL) patients induces also significant disease response without toxicity

HAEMATOLOGICA(2017)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要